Centromeres, epigenetically defined by the presence of the histone H3 variant CenH3, are essential for ensuring proper chromosome segregation. In mammals, centromeric CenH3 CENP-A deposition requires its dedicated chaperone HJURP and occurs during telophase/early G1. We find that the cell-cycledependent recruitment of HJURP to centromeres depends on its timely phosphorylation controlled via cyclin-dependent kinases. A nonphosphorylatable HJURP mutant localizes prematurely to centromeres in S and G2 phase. This unregulated targeting causes a premature loading of CenH3 CENP-A at centromeres, and cell-cycle delays ensue. Once recruited to centromeres, HJURP functions to promote CenH3 CENP-A deposition by a mechanism involving a unique DNA-binding domain. With our findings, we propose a model wherein (1) the phosphorylation state of HJURP controls its centromeric recruitment in a cell-cycle-dependent manner, and (2) HJURP binding to DNA is a mechanistic determinant in CenH3 CENP-A loading.
INTRODUCTION
The centromere is a specialized chromosomal domain usually defined by the primary constriction site on chromosomes (Flemming, 1882) . During mitosis, it serves as the site for kinetochore assembly, a multiprotein complex that mediates spindle microtubule attachment (Cleveland et al., 2003) . This specific organization ensures correct chromosome segregation and equal distribution of sister chromatids to both daughter cells during cell division. With the exception of budding yeast (Cheeseman et al., 2002) , centromeres are not simply defined by an underlying DNA sequence but rather by chromatin features. This has led to consider centromeres as epigenetically defined chromosomal regions (reviewed in Allshire and Karpen, 2008; Probst et al., 2009 ). All eukaryotic centromeres are marked by a specific histone H3 variant (Black and Bassett, 2008; Fachinetti et al., 2013; Lacoste et al., 2014) . Originally identified in mammals as CENP-A (Earnshaw and Rothfield, 1985) , it has recently been called CenH3 CENP-A , using a nomenclature currently in discussion Earnshaw and Cleveland, 2013; Mü ller and Almouzni, 2014; Talbert et al., 2012; Talbert and Henikoff, 2013) . Although this particular variant has been identified in many eukaryotic species, the timing of its incorporation differs between organisms (Allshire and Karpen, 2008; Boyarchuk et al., 2011) . In S. cerevisiae, CenH3 Cse4 incorporation occurs during DNA replication in S phase (Pearson et al., 2004) , and in S. pombe, CenH3 Cnp1 deposition takes place in early S phase and continues until G2 phase (Takayama et al., 2008) . However, in mammalian cells, CenH3 CENP-A is diluted in S phase and distributed evenly to both daughter strands, and subsequently, its deposition is restricted to late telophase/early G1 (Jansen et al., 2007 ) ( Figure 1A ). A similar dilution in S phase is observed in D. melanogaster, but CenH3 CID assembly occurs between metaphase and anaphase as found in cultured fly cells (Mellone et al., 2011; Schuh et al., 2007) . Much progress has been made concerning the understanding of the complex network of molecular players involved in the incorporation and maintenance of CenH3 at centromeres in different species (reviewed in Mü ller and Almouzni, 2014), but how they actually act at different times during the cell cycle remains elusive. The vertebrate CenH3 CENP-A -specific histone chaperone Holliday junction recognition protein (HJURP) Foltz et al., 2009) , or its yeast homolog suppressor of chromosome missegregation protein 3 (Scm3) Shivaraju et al., 2011) , plays a central role for the proper incorporation of CenH3 into centromeric chromatin. In D. melanogaster, the protein Chromosome alignment defect 1 (CAL1) is the dedicated CenH3 CID chaperone but is not conserved with HJURP or Scm3. Notably, HJURP misregulation can lead to chromosome instability and mitotic defects (Dunleavy et al., 2009; Mishra et al., 2011) . Its direct artificial targeting is sufficient to form a functional de novo kinetochore in human cells (Barnhart et al., 2011) . Interestingly, overexpression of CenH3 CENP-A in cultured human cells leads to an enrichment at noncentromeric regions (Choi et al., 2011; Gascoigne et al., 2011) . In this case, it is not HJURP but rather the H3.3 dedicated histone chaperone DAXX that is key for this ectopic localization (Lacoste et al., 2014) . This is raising the issue of how HJURP can be specific for the targeting of CenH3 CENP-A strictly to centromeres, what is controlling the cell-cycle timing, and whether it has a mechanistic function to promote CenH3 CENPA loading. In this respect, it is interesting to note that the cell-cycle timing of CenH3
CENPA loading is coupled to the activity of cyclin-dependent kinase (CDK) 1 and 2, which phosphorylate Mis18BP (Silva et al., 2012) . The latter is a subunit of the Mis18 complex (consisting of Mis18BP, Mis18a, and Mis18b), thought to prepare chromatin to be receptive for the loading of new CenH3 CENP-A (Fujita et al., 2007) . CDK1 activity increases at the end of G1, peaks toward the end of G2/early M, and is reduced in anaphase, and CDK2 activity increases in mid-G1 and peaks in S/G2 (reviewed in Arellano and Moreno, 1997) (see Figure 1A ). Interestingly, phosphorylation of HJURP and its ability to interact with DNA in vitro were discovered prior to its finding as a dedicated CenH3 CENP-A chaperone (Kato et al., 2007) . Although early reports showed the involvement of the ATM kinase, more recent work showed that CDK1 can ensure a direct phosphorylation in vitro (Wang et al., 2014) . Thus, which kinase can control HJURP phosphorylation in vivo remains unclear. However, more importantly, how such phosphorylation can contribute to HJURP function for a specific recruitment to centromeres specifically in telophase/early G1 has to be established. The recruitment of HJURP to centromeres is independent from its CenH3 CENP-A -binding domain (Zasadzi nska et al., 2013) ; thus, the interaction with CenH3 CENPA to facilitate targeting can be excluded. Therefore, it is important to consider other domains of HJURP and whether their phosphorylation states depend on the cell cycle. The modular organization of HJURP reveals several key features. Its N-terminal histone-binding domain interacts with CenH3
CENP-A as a predeposition complex with histone H4 (Bassett et al., 2012; Hu et al., 2011; Shuaib et al., 2010 
RESULTS
Cell-Cycle-Dependent Centromeric Localization of HJURP Is Controlled by CDK Activity We postulated that CDKs directly control the localization of HJURP to centromeres in a cell-cycle-dependent manner (Figure 1A) . To test this hypothesis, we investigated the effect of the kinase inhibitor Roscovitine on HJURP localization to centromeres in early G1, S, and G2 phase. Roscovitine strongly inhibits CDK1/CDK2 but also shows a broad spectrum of inhibition of other kinases. We used EdU or Aurora B as cell-cycle markers for S and G2, respectively, and human anticentromere antibody (ACA) as a centromeric marker ( Figure S1A ). Because HJURP can dimerize (Zasadzi nska et al., 2013) , the presence of endogenous HJURP may obscure phenotypic effects of exogenous protein. Thus, we downregulated endogenous HJURP using small interfering RNA (siRNA) against the 3 0 UTR (siHJ), as evidenced by western blotting ( Figure 1B) . We found that treatment with Roscovitine did not impair localization of GFP-HJURP in early G1. However, GFP-HJURP localized to centromeres in S and G2 upon treatment with Roscovitine ( Figure 1B ). The presence of Roscovitine did not alter the expression levels of GFP-HJURP as shown by western blotting. As a positive control for the efficiency of Roscovitine treatment, we monitored the dephosphorylation of CAF-1 p60, which was previously reported to lose its phosphorylation as a result of Roscovitine treatment (Marheineke and Krude, 1998) (Figure S1B ). We also tested another CDK1/CDK2 inhibitor, Purvalanol A. Both inhibitors did not alter the cell-cycle profile under the conditions used (Figure S1C) . Treatment of cells with Purvalanol A also resulted in centromeric HJURP recruitment in S and G2 ( Figure S1D ). Taken together, this suggests that CDK activity regulates HJURP recruitment during the specific time window of late telophase/early G1 in a cell-cycle-dependent manner.
Phosphorylation of the HCTD1 Is Regulated in a Cell-Cycle-Dependent Manner Next, we investigated whether the HJURP phosphorylation state changes at the M/G1 transition. For that, we synchronized U2OS cells with nocodazole and collected total cell extracts (1) (legend continued on next page) directly after nocodazole release (M phase) and (2) 1 hr after release (early G1) and treated the extracts with l phosphatase (Figure 2A ). Nocodazole impairs microtubule polymerization and thus arrests cells in prometaphase. Upon nocodazole release, the cells pass through mitosis, and the population is enriched in G1 phase 1 hr after release ( Figure S2A ). A band shift in the western blot, indicative of HJURP phosphorylation, shows an increase in mitosis as compared to early G1 ( Figure 2A ). Treatment with l phosphatase indicates that the higher band corresponds to hyperphosphorylated HJURP. This hyperphosphorylation in mitosis is lost upon entry into G1. Thus, a decrease in HJURP phosphorylation likely takes place at the end of mitosis. Next, we aimed to identify the phosphorylation sites of HJURP. For this, we transiently transfected U2OS cells with GFP-HJURP and pulled down the protein using the GFP-Trap system (Figure S2B) . Subsequently, we isolated the corresponding band and searched for posttranslational modifications by mass spectrometry (MS). We found several phosphorylation sites, and some of these corresponded to CDK consensus sites (Dephoure et al., 2008) , as depicted in Figure 2B . Three residues, which also correspond to CDK consensus sites (Ser412, Ser448, and Ser473) found inside or just adjacent to the HCTD1 ( Figure S2C ), attracted our attention. Indeed, this region proved to be important for HJURP localization to centromeres (Zasadzi nska et al., 2013) . We quantified the phosphorylation of the HCTD1 of GFP-HJURP isolated from M phase and G1 phase of the cell cycle by MS and found that phosphorylation decreased in G1 as compared to M phase. We also observed a decrease of phosphorylation of the HCTD1 in cells treated with Roscovitine (Figure S2D ). Taken together, this suggests that Ser412, Ser448, and Ser473 are key residues of HJURP that undergo a decrease in phosphorylation at the M/G1 transition.
HJURP Phosphomutants Show Aberrant Cell-Cycle Localization at Centromeres
We then investigated the importance of these phosphorylation sites in the HCTD1 on centromeric HJURP localization. We generated distinct GFP-tagged mutants and studied their centromeric recruitment in a cell-cycle-dependent manner. In agreement with a previous report by Zasadzi nska et al. (2013), the HCTD1 proved crucial for the recruitment of HJURP to centromeres ( Figures S3A-S3C ). Interestingly, our data also highlight that HJURP recruitment to centromeres is independent from its CenH3 CENP-A -binding domain. Next, we generated a nonphosphorylatable triple mutant (Ala 412, 448, 473 ) by mutating the three serine residues in the HCTD1, which we had identified to be phosphorylated by MS, to alanine (Ala) ( Figure 2B ). We then studied the centromeric localization of this mutant throughout the cell cycle. We transiently transfected the WT GFP-HJURP or Ala 412,448,473 into U2OS cells in the presence of siHJ. As expected, WT localized to centromeres in early G1, but not in S and G2 ( Figure 2C ). Ala 412,448,473 also localized to centromeres in G1 in the same percentage of cells. Strikingly, in addition to G1, Ala 412, 448, 473 was also recruited to centromeres in S and G2. We also generated the phosphomimic Glu 412, 448, 473 to compare its centromeric localization throughout the cell cycle with WT and Ala 412, 448, 473 . We cotransfected the constructs transiently in U2OS cells together with siHJ or siRNA against luciferase (siLuc) as a control. We verified by western blotting that both mutants and the WT construct expressed at similar levels, and siHJ downregulated endogenous HJURP but did not affect expression levels of the GFP-HJURP constructs ( Figure S4A ). We counted the cells with centromeric GFP signal of the WT and the mutants in the different cell-cycle phases ( Figure S4A to centromeres in S and G2. In order to dissect if these three residues act synergistically or if a single one is crucial for the observed aberrant cell-cycle localization of HJURP, we mutated these residues consecutively to Ala to generate the three single mutants Ala . We found that all three single mutants localized to centromeres in G2, but this effect was more pronounced for the triple mutant Ala 412,448,473 ( Figure S4B ). This suggests that cumulative dephosphorylation of all three residues facilitates HJURP localization to centromeres. Taken together with our observations with Roscovitine, we draw the following conclusions. First, dephosphorylation of the HCTD1, namely at Ser412, Ser448, and Ser473, leads to HJURP recruitment to centromeres in telophase/early G1. Second, phosphorylation favors HJURP dissociation from centromeres.
HJURP Interacts with DNA through a Single Conserved Domain Independently of CDK Activity Given the previous characterization of HJURP as a DNA-interacting protein in vitro (Kato et al., 2007) and identification of an N-terminal DNA-binding region of Scm3 of S. cerevisiae (Xiao et al., 2011) , we hypothesized that HJURP interaction with DNA could play a role in centromeric localization and/or the centromeric-loading mechanism of CenH3 CENP-A . First, we used a DNA-binding prediction software called DB-Bind (Hwang et al., 2007; Kuznetsov et al., 2006) to find putative DNA-binding regions of HJURP and Scm3 in various species ( Figure 3A) . With this method, in agreement with previous experimental data (Xiao et al., 2011) , we verified the DNA-binding domain in the N-terminal region of Scm3 in S. cerevisiae. Interestingly, the Scm3 sequences of the different species showed no predicted conservation of the N-terminal DNA-binding region of S. cerevisiae. Surprisingly, in all the vertebrate species we investigated, this method predicted a DNA-binding region within the Figure 3A) . Next, we used a DNA-binding assay, with DNA coupled to streptavidin magnetic beads (Mello et al., 2004; Ray-Gallet et al., 2011) and cell extracts. Using U2OS salt-extractable extracts (Martini et al., 1998) , we looked at the retrieved proteins on the DNA beads including the HJURP complex, i.e., HJURP, Npm1, RbAp48, and CenH3 CENP-A Shuaib et al., 2010) . We did not detect any signal with our control beads ( Figure 3B ). The presence of the histone H3.3 chaperone complex HIRA served as a positive control, whereas the histone H3.1 histone chaperone complex CAF-1 served as a negative control, consistent with our previous work (Ray-Gallet et al., 2011) . Because the interaction in the extract can be indirect, it was important to test if HJURP interacts directly with DNA using recombinant protein. We thus produced glutathione S-transferase (GST)-HJURP and several mutants (Figures 3C and S5C) and tested these purified recombinant proteins for DNA interaction in the binding assay. We found that full-length HJURP interacts with DNA and that deleting the predicted DNA-binding region (285-321) abrogated its ability to bind DNA. Notably, the CenH3
CENP-A -binding domain and the HCTD1, important for centromeric localization of HJURP, proved dispensable for DNA binding ( Figure 3C ). Because the sequence of the HMD is not conserved with other DNA-binding proteins (Sanchez-Pulido et al., 2009) , this may constitute a new type of DNA-binding domain.
We then investigated if CDK activity influences the binding of HJURP to DNA. We thus used extracts from cells treated with or without Roscovitine in the DNA-binding assay. We found that there was no difference in DNA binding ( Figure 3D ). Thus, CDK activity does not control the binding activity of HJURP to DNA as assayed in our experiments. These data suggest that HJURP is able to directly interact with DNA through a conserved DNA-binding domain in the HMD, independently of CDK activity.
De Novo Deposition of CenH3
CENP-A in Early Figure S6A ). The SNAP-tag technology allows fluorescent labeling of newly synthesized proteins to distinguish them from the total protein pool. This method allows to study the de novo deposition of CenH3
CENP-A at centromeres (Jansen et al., 2007) . After quenching old SNAP-CenH3 CENP-A protein with O 6 -benzylguanine (Q), the chase (C) period allows new protein synthesis, and a pulse (P) of tetramethylrhodamine (TMR) ensures the labeling of de novo-deposited SNAP-CenH3 CENP-A (QCP assay). Concomitantly, we synchronized cells with nocodazole and released them into early G1, as shown in Figure 4A . Downregulation of endogenous HJURP caused a reduction of the signal of de novo-incorporated CenH3 CENP-A to 38% upon treatment with siHJ compared to the control treated with siLuc ( Figure 4A ). Figure 4A ). By western blot, we verified that expression of all constructs was at comparable levels and downregulation of endogenous HJURP effective by siHJ ( Figure 4A ). Figures 4B and S5D ). In contrast, the cell-cycle profile of cells expressing D285-321 was comparable to cells expressing the WT. Endogenous HJURP is still present and can thus deposit CenH3 CENP-A in telophase/early G1, both in the presence of D285-321 and Ala 412, 448, 474 . We counted mitotic cells 72 hr posttransfection using H3S10P as a marker, and whereas cells expressing WT or D285-321 showed a similar mitotic index, it was decreased in cells transfected with Ala 412,448,473 ( Figure 4C ). Trypan blue exclusion 72 hr posttransfection ( Figure S6B) showed no difference in viability between WT and Ala 412,448,473 -treated cells but a decrease in viability caused by D285-321. Using a colony formation assay, we assessed long-term proliferation by counting colonies 12 days posttransfection. We observed a decrease in colony number for Ala 412, 448, 473 and D285-321, which was more pronounced for the latter ( Figure S6C we assessed if HJURP is involved in the aberrant loading of CenH3 CENP-A in S and G2 upon Roscovitine treatment (Silva et al., 2012) . We synchronized SNAP-CenH3 CENP-A U2OS cells using a single thymidine block and released them after 3 hr (enriched in mid-S) or 8 hr (enriched in G2) ( Figure S6D ). We transfected cells either with siHJ or siLuc and treated them with Roscovitine. We saw a reduction of relative TMR fluorescence at centromeres in cells treated with siHJ as compared to cells treated with siLuc, both in S and G2 ( Figure 5A ). Cells were selected based on Aurora B or EDU staining typical for these cell-cycle phases. We observed a similar effect upon treatment with Purvalanol A ( Figure S6E ) and controlled the downregulation of endogenous HJURP by western blotting ( Figure 5A ). Taken and released them after 3, 6, or 8 hr to enrich cells in mid-S, late S, or G2, respectively ( Figure S6D ). We counted TMR-positive cells in mid-S, late S, and G2, selected by Aurora B or EDU staining typical for these cell-cycle phases. Strikingly, we found TMR-positive cells in 26% of Ala 412, 448, 473 -positive cells in G2 but hardly any in mid-S or late S ( Figure 5B mutant, but not with the WT (Figures S6D-S6G ). Taken 
DISCUSSION
The CenH3 CENP-A chaperone HJURP plays a major role in centromere maintenance through its escort function for CenH3 CENP-A . It is a highly divergent protein with four distinct domains: the Scm3 domain, the HMD, the HCTD1, and the HCTD2 (Sanchez-Pulido et al., 2009) . We found that the phosphorylation state of the HCTD1 is coupled to CDK activity and thus determines the recruitment of HJURP to centromeres specifically in telophase/early G1 (Figures 1 and 2) . We also discovered that the HMD harbors a DNA-binding domain (Figure 3 ), which plays a role in the loading of CenH3
CENP-A at centromeres (Figure 4) . Premature recruitment of a nonphosphorylatable HJURP mutant to centromeres leads to CenH3 CENP-A deposition in G2 ( Figure 5 ). Thus, we assign additional functionalities to two domains of HJURP: the HMD and the HCTD1. Our model is presented in Figure 6 . Whereas the phosphorylation state of the HCTD1 determines the cell-cycle-dependent recruitment of HJURP to centromeres, the DNA-binding region of the HMD is necessary for CenH3 CENP-A loading by HJURP, assigning another function to HJURP in addition to its escorting role of CenH3 CENP-A . Our findings lead us to propose a threestep mechanism of the chaperone function of HJURP for CenH3 CENP-A , as depicted in Figure 6B . In step 1, HJURP is phosphorylated at the HCTD1 during most of the cell cycle and dephosphorylated at late stages of mitosis, concomitant with CDK1/CDK2 downregulation. This dephosphorylation causes a recruitment of HJURP to centromeres in telophase. In step 2, HJURP has a role in the loading process of CenH3 CENP-A at centromeres, where it functions mechanistically through a direct , and D285-321, cotransfected with siHJ. TMR-CenH3 corresponds to newly incorporated CenH3 CENP-A at centromeres. interaction with DNA between telophase and early G1. This leads to an increase of CenH3 CENP-A at centromeres. In step 3, increased CDK activity leads to HJURP phosphorylation, which causes a dissociation of HJURP from centromeres where CenH3 CENP-A has been deposited. Interestingly, the premature recruitment of Ala 412, 448, 473 to centromeres results in CenH3 CENP-A loading in a subset of cells in G2, but not in S, whereas treatment with CDK inhibitors causes deposition in G2 and S. Thus, it is possible that during Cen-H3 CENP-A loading, HJURP may act in concert with (an)other CDK-responding factor(s) recruited in G2/M such as Mis18BP or Mis18b (Silva et al., 2012; Wang et al., 2014) . Although we highlight here a temporal control for the loading CenH3 CENP-A , this control shows plasticity in different species and possibly during development. This is exemplified in flies with the timing of CenH3 CID deposition, which is altered in meiosis, when loading occurs during premeiotic G2, prophase I, and the spermatid stage in males and over a period of days during prophase I in females (Dunleavy et al., 2012; Raychaudhuri et al., 2012) . In C. elegans, which have holocentromeres, an extreme situation has been reported. Unlike in vertebrates and flies, CenH3 is lost in meiosis (Gassmann et al., 2012; Monen et al., 2005) , and both oocyte meiotic divisions proceeded normally and recruited kinetochore proteins in the absence of CenH3 . Surprisingly, a specific CenH3 -loading factor has not yet been identified in this species because C. elegans have neither HJURP nor CAL1. Thus, the loading mechanism of CenH3 in a developmental context in other model organisms certainly illustrates an important plasticity. Dissecting this further might shed more light on the mechanisms of CenH3 recruitment and loading by its dedicated chaperone, such as CAL1 or HJURP. Step 1: HJURP recruitment (telophase)
Step 3: HJURP dissociation (G1)
Step 2: CenH3 CENP-A loading (telophase to early G1)
CenH3 H4 Step 1, HJURP is dephosphorylated in the HCTD1, which leads to its recruitment to centromeres in telophase/early G1, concomitant with reduced CDK1/CDK2 activity. In
Step 2, HJURP loads CenH3 CENP-A at centromeres between telophase/early G1. It is actively involved in this process through its DNA-binding domain. In
Step 3, HJURP is phosphorylated in the HCTD1, leading to a dissociation from centromeres, concomitant with increased CDK1/CDK2 activity.
A recent report proposed that Mis18b interacts with HJURP to recruit it to the centromere (Wang et al., 2014) . Another recent study reported an interaction between HJURP and And-1, a protein required for CenH3 (Okada et al., 2006) , and Mis18 (Dambacher et al., 2012; Wang et al., 2014) are all required for CenH3 CENP-A deposition at centromeres in telophase/early G1. The presence of various other factors in the HJURP complex, including RbAp46/48 and Npm1, likely participates in these dynamics . Future studies should address if and how these factors are involved in the mechanism of centromeric HJURP recruitment and/or the HJURP-mediated loading mechanism. The different effects of the nonphosphorylatable mutant Ala 412, 448, 473 and the DNA-binding mutant D285-321 on the cell cycle and on cell proliferation highlight the difference of the functionality of the HMD and the HCTD1 in HJURP localization to centromeres and CenH3 CENP-A loading, respectively. Taken together, our finding of a conserved DNA-binding region in the HMD of HJURP and its requirement for the loading of CenH3 CENP-A at centromeres provide insight into an active role for HJURP in the CenH3 CENP-A -loading mechanism. Given the preference of HJURP to interact with noncanonical DNA structures, in particular Holliday Junctions (Kato et al., 2007) , this contribution to the loading mechanism might be mediated through structural changes of centromeric DNA. Interestingly, the HMD, including the newly identified DNA-binding domain, does not show a particular sequence conservation with other known DNA-binding proteins (Sanchez-Pulido et al., 2009) . Therefore, future studies involving structural analyses of the HMD and how it interacts with DNA will be required to look into this issue in more detail. Currently, histone chaperones are regarded as escort factors for their designated histone variants (reviewed in De Koning et al., 2007) . We find that the functionality of HJURP as an active mechanistic participant in CenH3 CENP-A loading through its DNA-binding domain is distinct from a simple targeting role. A previous report showed that HIRA can interact with naked DNA, but this property is not common to all chaperones (Ray-Gallet et al., 2011) . This raises the question as to whether other histone chaperones may also have similar additional roles in the histone-loading process. Thus, dissecting their loading mechanisms will be an interesting avenue for future research.
EXPERIMENTAL PROCEDURES Cell Synchronization and Drugs
For synchronization in M and early G1, we incubated cells for 16 hr with nocodazole (Sigma-Aldrich) at 100 ng/ml. We subsequently washed the cells 23 with PBS and collected them (M phase/FACS) or plated them on collagen/ fibronectin-coated coverslips (Sigma-Aldrich) or in culture dishes. We incubated them for 1 hr (early G1 for FACS) or 2 hr (early G1 for microscopy). For synchronization in G2 or S, we used a single thymidine block: we added thymidine (Sigma-Aldrich) to the cells (4 mM) and incubated them for 18 hr. Cells were washed 23 with PBS and 13 with medium and incubated in the presence of deoxycytidine (Sigma-Aldrich; 0.5 mM). We incubated cells with Roscovitine at 100 mM (Sigma-Aldrich) and Purvalanol A at 24 mM (SigmaAldrich) for 2 hr prior to fixation as indicated.
Transfection and siRNA
We transfected siRNAs and plasmids with jetPrime (Polyplus) according to the manufacturer's protocol. In a typical experiment, 24%-36% of cells were transfected with GFP-HJURP or the mutants. The siRNA sequences were ordered from MWG Eurofins and were as follows: siHJ, 5 0 -GAG-AUA-ACC-UCG-AGU-UCU-UTT-3 0 ; and siLuc (control), 5 0 -CGU-ACG-CGG-AAU-ACU-UCG-A-3 0 .
Fluorescent Labeling for Microscopy
We performed pre-extraction of cells prior to fixation for 5 min with 0.5% Triton X-100 in CSK buffer as described by Martini et al. (1998) and fixed cells in 2% paraformaldehyde for 20 min. We blocked cells with BSA (5% in PBS, 0.1% Tween 20) before incubation with 1ry and 2ry antibodies and DAPI staining. For in vivo labeling of SNAP-tagged CenH3 CENP-A , we used the SNAP-labeling protocol as described by Jansen et al. (2007) and Ray-Gallet et al. (2011) . We added 10 mM of SNAP-Cell Block (New England Biolabs) to cell medium at 37 C for 30 min to quench SNAP-tag activity (Q) and 2 mM SNAP-Cell TMRStar (New England Biolabs) for 20 min for pulse labeling (P). We washed the cells 23 with PBS, reincubated them in medium for 10 min, and washed the cells 23 with PBS. For the chase (C), we incubated the cells for the indicated length of time. After in vivo labeling, the cells were processed for immunostaining. Synchronization with nocodazole or thymidine was incorporated into this protocol. For EdU labeling, we used the Click-iT EdU Alexa kit (Life Technologies) according to the manufacturer's instructions. To enhance GFP signals, we used the GFP-Trap booster (ChromoTek) at a dilution of 1:200, which was used prior to click chemistry in case of EdU labeling.
Pull-Down Studies
We produced GST-HJURP recombinant protein as described by Dunleavy et al. (2009) and obtained bead-linked plasmid DNA (PUC19) as described (Mello et al., 2004; Ray-Gallet et al., 2011) . Mock beads or DNA beads were blocked with BSA (1 mg/ml) and incubated 1 hr at 30 C with 100 mg U2OS salt-extractable extracts or 100 ng recombinant proteins in buffer containing 10 mM HEPES (pH 7.8), 2 mM MgCl 2 , 1 mM CaCl 2 , 0.5 mM EGTA, 100 mM NaCl, 0.1% NP40, and 8% glycerol in a final volume of 50 ml. Then, the beads were washed 33 in the presence of 300 mM NaCl and 0.5% NP40. We analyzed bound proteins by western blot. We pulled down GFP-HJURP using GFP-Trap (ChromoTek) according to the manufacturer's protocol.
Antibodies
We used the following primary antibodies for western blotting: rabbit anti-HJURP (Sigma-Aldrich; #HPA008436, 1:500); rabbit anti-GFP (#A-P-R#06, in-house platform of Institut Curie, 1:1,000); anti-a-tubulin (Sigma-Aldrich; #T9026, 1:2,000); anti-Cabin1 (Abcam; #ab76600, 1:1,000); anti-HIRA (Active Motif; #WC119.2H11, 1:200); anti-Npm1 (Abcam; #ab15440, 1:1,000); antiCenH3 Cenp-A (Cell Signaling Technology; #2186, 1:500); anti-RbAp48 (Abcam; ab1765, 1:1,000); anti-Caf-1 p150 (Abcam; #7655, 1:1,000); anti-CAF-1 p60 (Abcam; #ab8133, 1:1,000); and anti-GST (Abcam; ab9085, 1:500). The H3S10P antibody was a gift from N. Nozaki (Japan). We used the following secondary antibodies for immunofluorescence: anti-CREST = ACA (Fitzgerald Industries/Interchim; #90C-CS1058, 1:1,000); anti-Aurora B (BD Transduction Laboratories; #611082, 1:2,000); and anti-CENP-B (Abcam; #ab25734, 1:500). For immunofluorescence, we used Alexa 488-, Alexa 594-, Alexa 647-, or Cy5-coupled antibodies (Molecular Probes).
MS Analyses
Samples were analyzed using a LTQ Orbitrap XL mass spectrometer (Thermo Scientific) coupled to a nano-liquid chromatography system (UltiMate 3000; Dionex). Details of the separation, MS parameters, and label-free quantification are described in Supplemental Experimental Procedures. 
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